Literature DB >> 21525490

Serum response factor expression is enriched in pancreatic β cells and regulates insulin gene expression.

Aloke Sarkar1, Mao Zhang, Shi-He Liu, Swapna Sarkar, F Charles Brunicardi, David H Berger, Narasimhaswamy S Belaguli.   

Abstract

Serum response factor (SRF) is an essential regulator of myogenic and neurogenic genes and the ubiquitously expressed immediate-early genes. The purpose of this study is to determine SRF expression pattern in murine pancreas and examine the role of SRF in pancreatic gene expression. Immunohistochemical analysis of wild-type pancreas and LacZ staining of pancreas from SRF LacZ knock-in animals showed that SRF expression is restricted to β cells. SRF bound to the rat insulin promoter II (RIP II) serum response element, an element conserved in both rat I and murine I and II insulin promoters. SRF activated RIP II, and SRF binding to RIP II and the exon 5-encoded 64-aa subdomain of SRF was required for this activation. Transient or stable knockdown of SRF leads to down-regulation of insulin gene expression, suggesting that SRF is required for insulin gene expression. Further, SRF physically interacted with the pancreas and duodenum homeobox-1 (Pdx-1) and synergistically activated RIP II. Elevated glucose concentration down-regulated SRF binding to RIP II SRE, and this down-regulation was associated with decreased RIP II activity and increased SRF phosphorylation on serine 103. Together, our results demonstrate that SRF is a glucose concentration-sensitive regulator of insulin gene expression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21525490     DOI: 10.1096/fj.10-173757

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  7 in total

1.  Neurokinin B induces c-fos transcription via protein kinase C and activation of serum response factor and Elk-1 in immortalized GnRH neurons.

Authors:  Christine A Glidewell-Kenney; Crystal Trang; Paul P Shao; Navarre Gutierrez-Reed; Adaku M Uzo-Okereke; Djurdjica Coss; Pamela L Mellon
Journal:  Endocrinology       Date:  2014-07-24       Impact factor: 4.736

2.  Beta cell dysfunction and insulin resistance.

Authors:  Marlon E Cerf
Journal:  Front Endocrinol (Lausanne)       Date:  2013-03-27       Impact factor: 5.555

3.  Npas4 is a novel activity-regulated cytoprotective factor in pancreatic β-cells.

Authors:  Paul V Sabatini; Nicole A J Krentz; Bader Zarrouki; Clara Y Westwell-Roper; Cuilan Nian; Ryan A Uy; A M James Shapiro; Vincent Poitout; Francis C Lynn
Journal:  Diabetes       Date:  2013-05-08       Impact factor: 9.461

4.  Serum response factor mediated gene activity in physiological and pathological processes of neuronal motility.

Authors:  Bernd Knöll
Journal:  Front Mol Neurosci       Date:  2011-12-06       Impact factor: 5.639

5.  Forkhead box protein A2 (FOXA2) protein stability and activity are regulated by sumoylation.

Authors:  Narasimhaswamy S Belaguli; Mao Zhang; F Charles Brunicardi; David H Berger
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

6.  Transcription factor Ets1 regulates expression of thioredoxin-interacting protein and inhibits insulin secretion in pancreatic β-cells.

Authors:  Yan Luo; Fengli He; Li Hu; Luo Hai; Meifeng Huang; Zhipeng Xu; Jingjing Zhang; Zhiguang Zhou; Feng Liu; Yan-Shan Dai
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240

7.  Molecular evidence of Zn chelation of the procaspase activating compound B-PAC-1 in B cell lymphoma.

Authors:  Aloke Sarkar; Kumudha Balakrishnan; Jefferson Chen; Viralkumar Patel; Sattva S Neelapu; John S McMurray; Varsha Gandhi
Journal:  Oncotarget       Date:  2016-01-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.